Phenotype and management of chronic obstructive pulmonary disease patients in general population in China: a nationally cross-sectional study
Heling Bao(National Center for Chronic and Noncommunicable Disease Control and Prevention), Yahong Chen(Wenzhou Medical University), Shu Cong(National Center for Chronic and Noncommunicable Disease Control and Prevention), Jeffrey L. Curtis(VA Ann Arbor Healthcare System), Jing Fan(National Center for Chronic and Noncommunicable Disease Control and Prevention), Ning Wang(National Center for Chronic and Noncommunicable Disease Control and Prevention), Baohua Wang(Gansu University of Traditional Chinese Medicine), Wanlu Sun(Peking University), Liwen Fang(Chinese Center For Disease Control and Prevention), Yajing Feng(Zhengzhou University), Guohua Jia(Wuhan University)
Cited by 8
Related Papers
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study
|The Lancet|2018|1.7k
Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD
|American Journal of Respiratory and Critical Care Medicine|2010|1k
Prevalence, risk factors, and management of asthma in China: a national cross-sectional study
|The Lancet|2019|759
Chronic obstructive pulmonary disease in China: a nationwide prevalence study
|The Lancet Respiratory Medicine|2018|477
Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease
|American Journal of Respiratory and Critical Care Medicine|2016|358